预计11月,国家医保局牵头“商保谈判”就将启动。但现在业界最好奇的一个问题是:商保就算谈好了价,到底靠什么保险来支付?此前,业界人士普遍认为,现阶段商保目录的落地大概率会附着于地方惠民保产品。对比,中国医药创新促进会执行会长宋瑞霖提出了不同的观点。10月23日,在国际生物医药产业创新北京论坛的创新药研发与评价高质量发展论坛上,宋瑞霖表示:“目前大家正在探讨商保如何建立,但是对以惠民保为基础的商保,...
Source Link预计11月,国家医保局牵头“商保谈判”就将启动。但现在业界最好奇的一个问题是:商保就算谈好了价,到底靠什么保险来支付?此前,业界人士普遍认为,现阶段商保目录的落地大概率会附着于地方惠民保产品。对比,中国医药创新促进会执行会长宋瑞霖提出了不同的观点。10月23日,在国际生物医药产业创新北京论坛的创新药研发与评价高质量发展论坛上,宋瑞霖表示:“目前大家正在探讨商保如何建立,但是对以惠民保为基础的商保,...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.